No results for ‘’
Fortis Healthcare Ltd
₹989.75
(0.07%)
Thu, 18 Jun 2026, 02:24 pm
Health Services
Hospital/Nursing Management
24.5KFortis Healthcare PE Ratio
| Particulars | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings ratio | 0 | 0 | 0 | 106.25 | 70.19 | 46.40 | 56.32 | 8.10 | 36.22 | 0 | 1350 | 20.30 | 0 | 0 | 164.26 | 0 | 39.49 | 33.33 | 52.93 | 68.11 |
| Price to book ratio | 0 | 0 | 1.65 | 1.46 | 3.09 | 1.87 | 1.25 | 1.09 | 1.06 | 1.88 | 1.95 | 1.81 | 1.58 | 1.55 | 1.43 | 2.45 | 3.55 | 2.71 | 4.14 | 5.91 |
| Price to sales ratio | 0 | 0 | 3.57 | 2.44 | 5.20 | 3.97 | 1.38 | 0.97 | 1.23 | 1.95 | 5.95 | 1.88 | 1.41 | 2.47 | 2.08 | 3.78 | 3.88 | 3.15 | 4.63 | 6.81 |
| Price to cash flow ratio | 0 | 0 | 0 | 66.86 | 45.10 | 0 | 33.75 | 3.69 | 20.65 | 0 | 141.88 | 7.18 | 16.58 | 24 | 324.61 | 36.37 | 28.98 | 27.22 | 30.68 | 38.43 |
| Enterprise value | 0 | 0 | 2209Cr | 1995Cr | 9083Cr | 6792Cr | 11345Cr | 11320Cr | 5873Cr | 9418Cr | 26334Cr | 11011Cr | 9063Cr | 12558Cr | 11389Cr | 16736Cr | 23596Cr | 21036Cr | 33148Cr | 54954Cr |
| Enterprise value to EBITDA ratio | 0 | 0 | 114.79 | 22.91 | 63.22 | 95.24 | 30.55 | 37.14 | 185.40 | 93.72 | 139.41 | 32.45 | 26.95 | 50.88 | 19.54 | 42.37 | 23.09 | 20.17 | 26.62 | 34.95 |
| Debt to equity ratio | 1.92 | 1.60 | 0.34 | 0.45 | 2.90 | 0.33 | 2.11 | 1.48 | 0.38 | 0.38 | 0.34 | 0.43 | 0.48 | 0.30 | 0.24 | 0.25 | 0.20 | 0.13 | 0.15 | 0.28 |
| Return on equity % | -36.06 | -28.31 | -7.44 | 1.31 | 4.70 | 4.85 | 2.21 | 12.85 | -5.59 | -2.45 | 0.36 | 8.78 | -21.93 | -5.61 | 0.87 | -1.72 | 9.03 | 8.77 | 8.04 | 9.34 |
Fortis Healthcare Ltd Price to Earnings Ratio
The Fortis Healthcare Ltd Price to Earnings Ratio is a key financial metric used by investors to evaluate Fortis Healthcare Ltd's valuation, profitability, and overall financial performance. Tracking the Fortis Healthcare Ltd Price to Earnings Ratio helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.
Fortis Healthcare Ltd (NSE: FORTIS, BSE: 532843) is currently trading at ₹989.75, with a market capitalization of ₹74586.09Cr. As a leading company in the Health services sector and Hospital/Nursing management industry, monitoring the Fortis Healthcare Ltd Price to Earnings Ratio is essential for fundamental analysis.
Fortis Healthcare Ltd Price to Earnings Ratio Current Value
The current Fortis Healthcare Ltd Price to Earnings Ratio stands at 68.11.
The latest Fortis Healthcare Ltd Price to Earnings Ratio has increased compared to the previous period, indicating rising valuation or improved investor sentiment.
Fortis Healthcare Ltd Price to Earnings Ratio Historical Trend
The Fortis Healthcare Ltd Price to Earnings Ratio has shown the following historical trend:
- 2024: 68.11
- 2023: 52.93
- 2022: 33.33
- 2021: 39.49
- 2020: 0
The recent rise in Fortis Healthcare Ltd Price to Earnings Ratio suggests strengthening valuation trends and improving market sentiment.
What Fortis Healthcare Ltd Price to Earnings Ratio Indicates for Investors
The Fortis Healthcare Ltd Price to Earnings Ratio plays a crucial role in understanding the company's financial health and valuation.
A higher P/E ratio indicates investors expect strong future earnings growth, while a lower ratio may signal undervaluation.
Fortis Healthcare Ltd Price to Earnings Ratio Analysis Summary
The Fortis Healthcare Ltd Price to Earnings Ratio remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking Fortis Healthcare Ltd Price to Earnings Ratio should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.
Regular tracking of Fortis Healthcare Ltd Price to Earnings Ratio helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.